NovaBay Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2011 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 3.71M shares, a 2669% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.22M shares, a 162% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.61M shares, a 29.1% increase from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.25M shares, a 96.4% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 3.71M +3.58M +2669% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 1.16M +1.06M +1169% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 24.7M +22.6M +1112% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.22M +2.61M +162% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 134K -1.47M -91.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 91K -1.42M -94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 2.04M +604K +42.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 1.61M +363K +29.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 1.6M -43.3M -96.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.51M -41.1M -96.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 1.43M -40.4M -96.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 1.25M -33.8M -96.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 44.9M +4.88M +12.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 42.6M +12.2M +40.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 41.8M +13.8M +49.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 35.1M +13.4M +62.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 40M +16.9M +73.4% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 30.4M +11.8M +63.2% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 28M +10.9M +63.7% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 21.6M +4.72M +27.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-29
Q3 2019 23.1M +6.01M +35.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 18.6M +1.52M +8.92% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 17.1M +687K +4.19% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 16.9M +1.6M +10.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 17.1M +1.77M +11.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 17.1M +1.78M +11.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 16.4M +1.12M +7.34% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 15.3M +5.92M +62.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 15.3M +4.41M +40.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 15.3M +7.9M +107% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 15.3M +11.2M +274% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 9.41M +6.62M +238% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-29
Q3 2016 10.9M -2.95B -99.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 7.41M -2.65B -99.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 4.09M +1.91M +87.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 2.78M +799K +40.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 2.96B +2.91B +5719% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 2.65B +2.6B +5126% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 2.18M -43.2M -95.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 1.99M +458K +30% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 50.8M +13.4M +35.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 50.8M +13.5M +36.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 45.3M +8.58M +23.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 1.53M -27.9M -94.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 37.5M +8.61M +29.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 37.3M +8.6M +30% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 36.8M +8.18M +28.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 29.4M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-26
Q3 2012 28.9M +959K +3.44% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 28.7M +5.19M +22.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 28.6M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q3 2011 27.9M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 23.5M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.